Login / Signup

Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists.

Cian O'MahonyKieran DaltonLeon O'HaganKevin Daniel MurphyClare KinahanEmma CoyleLaura J SahmStephen ByrneCiara Kirke
Published in: International journal of clinical pharmacy (2024)
Person-centred medicines reviews by general practice pharmacists for patients at high risk of medicines-related harm result in substantial cost savings. Wider investment in general practice pharmacists will be beneficial to minimise both patient harm and healthcare system expenditure.
Keyphrases
  • general practice
  • primary care
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • systematic review
  • life cycle